Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Other Short-Term Financial Investments
QFRD210385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
25,548.00
Year-over-Year Change
-7.63%
Date Range
10/1/2000 - 4/1/2025
Summary
This trend tracks quarterly short-term financial investments by U.S. pharmaceutical and medicine corporations. It provides critical insights into corporate financial strategies and liquidity management within a key healthcare sector.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The data represents financial allocation decisions made by pharmaceutical companies regarding their liquid assets and investment portfolios. Economists analyze these investments as indicators of sector confidence, cash flow management, and potential strategic positioning.
Methodology
Data is collected through comprehensive quarterly financial reporting by corporations in the pharmaceuticals and medicines industry, compiled and standardized by federal economic research agencies.
Historical Context
This trend is used by financial analysts, policymakers, and investors to assess corporate financial health, investment trends, and potential economic indicators in the healthcare sector.
Key Facts
- Represents quarterly financial investment data for U.S. pharmaceutical corporations
- Provides insights into corporate financial strategy and liquidity management
- Tracked and reported by federal economic research institutions
FAQs
Q: What does this economic trend measure?
A: It measures short-term financial investments made by U.S. pharmaceutical and medicine corporations on a quarterly basis.
Q: Why are these investments important?
A: These investments indicate corporate financial health, strategic planning, and potential economic trends in the healthcare sector.
Q: How frequently is this data updated?
A: The data is typically updated quarterly, providing a current snapshot of corporate financial strategies.
Q: Who uses this economic trend?
A: Financial analysts, investors, policymakers, and researchers use this trend to understand corporate financial dynamics.
Q: What are the limitations of this data?
A: The data represents a specific sector and may not fully capture the entire economic landscape or individual corporate variations.
Related Trends
Quarterly Financial Report: U.S. Corporations: Petroleum and Coal Products: Net Income Retained in Business
QFRNIRB324USNO
Quarterly Financial Report: U.S. Corporations: Scientific Research and Development Services: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans
QFRD319547USNO
Quarterly Financial Report: U.S. Corporations: All Other Retail Trade: Interest Expense
QFR105OTRUSNO
Quarterly Financial Report: U.S. Corporations: Aerospace Products and Parts: Other Direct Credits (Charges) to Retained Earnings (Net)
QFRD122386USNO
Quarterly Financial Report: U.S. Corporations: Fabricated Metal Products: Trade Accounts and Trade Notes Payable
QFR306332USNO
Quarterly Financial Report: U.S. Corporations: All Wholesale Trade: Property, Plant, and Equipment
QFR216WHSUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Other Short-Term Financial Investments [QFRD210385USNO], retrieved from FRED.
Last Checked: 8/1/2025